Look For Capital In Biotech Sector: RCUS, MRK, XNCR, LPTX, ARGX, BPMC
b'The biotech sector is down about 25% year-to-date. The SPDR S&P Biotech ETF (XBI) has been bouncing back and forth. "I like Arcus Biosciences (RCUS) as they have a partnership with Gilead Sciences (GILD). The company has capital to keep it going. Other stock picks include Xencor (XNCR), Merck & Co. (MRK), and Leap Therapeutics (LPTX)," says Mara Goldstein. Next, David Nierengarten weighs in on argenx SE (ARGX) and Blueprint Medicines (BPMC) stocks.'